Genmab — Marts 2026

[KWC]

Tak EL -...

[E_L]

Healio Disruptive Innovators Awards 2026, nominees for the Industry Breakthrough awards (goes to a product that stands out as a major disruption to the practice of hematology/oncology.) , 2 of the 6 are Genmabs , Dara and Epco https://www.surveymonkey.com/r/HealioInnovators

[gentogen]

Thanks (again) EL. From 09.30 link: As of January 15, 2025 (median follow-up 40.4 months), overall response rate (primary endpoint) was 79%, and complete response rate was 69%. !!!

[gentogen]

These findings suggest the potential of epcoritamab combined with standard chemoimmunotherapy as an effective salvage treatment for patients with R/R DLBCL.

[peter12]

Det er vist en gl. nyhed fra december https://www.prnewswire.com/news-releases/unprecedented-results-from-the-phase-3-majestec-3-study-support-tecvayli-plus-darzalex-faspro-as-a-potential-standard-of-care-as-early-as-second-line-for-patients-with-relapsedrefractory-multiple-myeloma-302636559.html

[gentogen]

Sandt nok, men dog fra en spritny artikel om det

[gentogen]

H. Lundbeck A/S (Lundbeck) today announced that the last patient has been randomized in MASCOT (NCT06706622), a global Phase 3 clinical trial evaluating amlenetug in people with multiple system atrophy (MSA)

[gentogen]

Early completion of randomization underscores the significant unmet need in MSA,

[E_L]

Lundbeck announces last patient randomized ahead-of-schedule in Phase 3 MASCOT trial / Amlenetug https://news.cision.com/h--lundbeck-a-s/r/lundbeck-announces-last-patient-randomized-ahead-of-schedule-in-phase-3-mascot-trial,c4318514

[E_L]

3 Acasunlimab posters at the European Lung Cancer Congress in Copenhagen later in March. Oh well, it is what it is.
https://cslide.ctimeetingtech.com/coasis_21526/attendee/confcal_1/presentation/list?q=acasunlimab

[E_L]

TECVAYLI▼ (teclistamab) monotherapy application submitted to the EMA for relapsed/refractory multiple myeloma after at least one prior therapy https://uk.finance.yahoo.com/news/tecvayli-teclistamab-monotherapy-application-submitted-092900331.html

[E_L]

jeez, BioNTech co-founders Ugur Sahin and Özlem Türeci will leave and establish an independent biotechnology company to research and develop next-generation mRNA innovations; management transition by end of 2026

[E_L]

https://investors.biontech.de/news-releases/news-release-details/biontech-and-co-founders-announce-plan-pursue-next-generation

[concillado]

As long as Genmab can have a strategic partnership with this new "sister-company" as well, is what I am more interested in. As these two individuals clearly have the abillity and focus to innovate new "knock-your-socks-off" products!

[peter12]

Fra Leerink webcast I dag med CCO og CFO:
De regner ikke med større M&A
2 ph3 readouts for Epco i 2026 (1L I løbet af året og 2L i H1)
2 readouts for RhinaS og Peto (sidst på året)
De forventer at Pato kan sælge 1mia$ i 2029

[Raun]

1722 i US lige nu - er det bare business as usual?

[E_L]

James Gordon CFA
Barclays
Buy Kr.2,500.00 Maintained Today 13-3-26

[Bella1]

Ham Gordon, må være på gin! - God weekend:-)

[Raun]

Hvis Gordon er på gin, så sidder han nok og skåler med kollegerne...

[gdn55]

Det er den jo ikke værd idag. Sådan er det jo med aktier, men hvis man bare gider at sætte sig lidt ind i tingene er den sansyndelig vis mindst det dobbelte værd.